Offering state-of-the-art facilities and expertise to scientists throughout California

UC Davis GMP Facility

In Spring 2008, CIRM gave $272 million for the construction of twelve stem cell research facilities in California. The University of California, Davis was one of the recipients of this Major Facilities grant.

UC Davis’ Good Manufacturing Practice facility in Sacramento features six manufacturing rooms with Class 10,000, multi-use cleanroom capabilities. It also offers an associated product scale-up and testing lab. Unique features include a GMP-grade FACS sorter, switchable positive-negative room pressurization for gene therapy vector manufacturing, and a hot cell for clinical grade PET reagent manufacturing. This state-of-the-art facility currently manufactures products for university investigators as well as other academic and industry partners. Reasonable hourly rates make it an ideal resource for both campus and external investigators.

Contact: Gerhard Bauer   gbauer@ucdavis.edu  |  916-703-9305

 


Guiding Principles

GMP lab
GMP Pass-throughs

  • Adherence to GMP regulations as required by the FDA
  • Precisely followed Standard Operating Procedure
  • Strict Quality Control (QC) and Quality Assurance (QA), with each being done by different individuals
  • Testing of final products according to FDA guidance and requirements 
  • Rigorous personnel training and proficiency testing
  • Meticulous documentation and record keeping
  • Readiness for audits

 


GMP Laboratory Goal

  • The manufacture of quality products for clinical application

 

Gerhard Bauer—GMP Laboratory Director

Gerhard BauerGerhard Bauer is an associate professor of hematology / oncology and the designer and director of the Good Manufacturing Practice (GMP) laboratory at the UC Davis Institute for Regenerative Cures. In addition to GMP facility design and construction expertise, Bauer also has extensive experience in gene and cell therapy, having spent more than two decades developing novel clinical applications in this field to improve medical outcomes for life-threatening illnesses.

He also has investigated potential therapies for HIV, replacing the devastated immune system of HIV-infected patients with cells that have been engineered to resist the virus. Bauer came to the UC Davis Health System in 2006 after designing and directing a state-of-the-art GMP laboratory at Washington University in St. Louis.